Authors:
MONGKONSRITRAGOON W
KIMLINGER T
AHMANN G
GREIPP PR
Citation: W. Mongkonsritragoon et al., IS MULTIDRUG-RESISTANCE (P-GLYCOPROTEIN) AN INTRINSIC CHARACTERISTIC OF PLASMA-CELLS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINEDSIGNIFICANCE, PLASMACYTOMA, MULTIPLE-MYELOMA AND AMYLOIDOSIS, Leukemia & lymphoma, 29(5-6), 1998, pp. 577-584
Authors:
MONGKONSRITRAGOON W
KYLE RA
SHRECK RR
GREIPP PR
Citation: W. Mongkonsritragoon et al., PRIMARY PLASMACYTOMA AT THE SITE OF EXIT WOUNDS AFTER ELECTRICAL INJURY, American journal of hematology, 58(1), 1998, pp. 77-79
Authors:
AHMANN GJ
JALAL SM
JUNEAU AL
CHRISTENSEN ER
HANSON CA
DEWALD GW
GREIPP PR
Citation: Gj. Ahmann et al., A NOVEL 3-COLOR, CLONE-SPECIFIC FLUORESCENCE IN-SITU HYBRIDIZATION PROCEDURE FOR MONOCLONAL GAMMOPATHIES, Cancer genetics and cytogenetics, 101(1), 1998, pp. 7-11
Authors:
KYLE RA
GREIPP PR
GERTZ MA
WITZIG TE
LUST JA
LACY MQ
THERNEAU TM
Citation: Ra. Kyle et al., WALDENSTROMS-MACROGLOBULINEMIA - A PROSPECTIVE-STUDY COMPARING DAILY ORAL VERSUS INTERMITTENT CHLORAMBUCIL, British Journal of Haematology, 102(1), 1998, pp. 244-244
Authors:
FONSECA R
WITZIG TE
GERTZ MA
KYLE RA
HOYER JD
JALAL SM
GREIPP PR
Citation: R. Fonseca et al., MULTIPLE-MYELOMA AND THE TRANSLOCATION T(11-14)(Q13-Q32) - A REPORT ON 13 CASES, British Journal of Haematology, 101(2), 1998, pp. 296-301
Authors:
KAY NE
LEONG T
BONE N
KYLE RA
GREIPP PR
VANNESS B
OKEN MM
Citation: Ne. Kay et al., T-HELPER PHENOTYPES IN THE BLOOD OF MYELOMA PATIENTS ON ECOG PHASE-III TRIALS E9486 E3A93/, British Journal of Haematology, 100(3), 1998, pp. 459-463
Authors:
MCELROY EA
WITZIG TE
GERTZ MA
GREIPP PR
KYLE RA
Citation: Ea. Mcelroy et al., DETECTION OF MONOCLONAL PLASMA-CELLS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH PRIMARY AMYLOIDOSIS, British Journal of Haematology, 100(2), 1998, pp. 326-327
Authors:
GREIPP PR
LEONG T
BENNETT JM
GAILLARD JP
KLEIN B
STEWART JA
OKEN MM
KAY NE
VANNESS B
KYLE RA
Citation: Pr. Greipp et al., PLASMABLASTIC MORPHOLOGY - AN INDEPENDENT PROGNOSTIC FACTOR WITH CLINICAL AND LABORATORY CORRELATES - EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) MYELOMA TRIAL E9486 REPORT BY THE ECOG MYELOMA LABORATORY GROUP, Blood, 91(7), 1998, pp. 2501-2507
Authors:
GERTZ MA
WITZIG TE
PINEDA AA
GREIPP PR
KYLE RA
LITZOW MR
Citation: Ma. Gertz et al., MONOCLONAL PLASMA-CELLS IN THE BLOOD STEM-CELL HARVEST FROM PATIENTS WITH MULTIPLE-MYELOMA ARE ASSOCIATED WITH SHORTENED RELAPSE-FREE SURVIVAL AFTER TRANSPLANTATION, Bone marrow transplantation, 19(4), 1997, pp. 337-342
Authors:
KYLE RA
GERTZ MA
GREIPP PR
WITZIG TE
LUST JA
LACY MQ
THERNEAU TM
Citation: Ra. Kyle et al., A TRIAL OF 3 REGIMENS FOR PRIMARY AMYLOIDOSIS - COLCHICINE ALONE, MELPHALAN AND PREDNISONE, AND MELPHALAN, PREDNISONE, AND COLCHICINE, The New England journal of medicine, 336(17), 1997, pp. 1202-1207
Citation: Pj. Papagelopoulos et al., PROSTHETIC HIP-REPLACEMENT FOR PATHOLOGICAL OR IMPENDING PATHOLOGICALFRACTURES IN MYELOMA, Clinical orthopaedics and related research, (341), 1997, pp. 192-205
Citation: Gj. Ahmann et al., IDENTIFICATION OF ANEUPLOID CELLS IN THE BLOOD OF PATIENTS WITH MULTIPLE-MYELOMA USING 3-COLOR CYTOPLASMIC IMMUNOGLOBULIN FLUORESCENCE IN-SITU HYBRIDIZATION (CIG-FISH), Blood, 90(10), 1997, pp. 1555-1555
Authors:
FONSECA R
AHMANN GJ
JUNEAU AL
JALAL SM
DEWALD GW
LARSON DR
THERNEAU TM
GREIPP PR
Citation: R. Fonseca et al., CYTOGENETIC ABNORMALITIES IN MULTIPLE-MYELOMA AND RELATED PLASMA-CELLDISORDERS - A COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS TO FLUORESCENT IN-SITU HYBRIDIZATION WITH SIMULTANEOUS CYTOPLASMIC IMMUNOGLOBULIN STAINING, Blood, 90(10), 1997, pp. 1558-1558
Authors:
FONSECA R
AHMANN GJ
JUNEAU AL
JALAL SM
DEWALD GW
LARSON DR
THERNEAU TM
GERTZ MA
GREIPP PR
Citation: R. Fonseca et al., CYTOGENETIC ABNORMALITIES IN SYSTEMIC AMYLOIDOSIS - A COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS TO FLUORESCENT IN-SITU HYBRIDIZATION WITH SIMULTANEOUS CYTOPLASMIC IMMUNOGLOBULIN STAINING, Blood, 90(10), 1997, pp. 1559-1559
Authors:
GREIPP PR
LEONG T
KAY NE
VANNESS BG
OKEN MM
KYLE RA
Citation: Pr. Greipp et al., FROM ECOG MYELOMA TRIAL E9486 - A PROGNOSTIC INDEX BASED ON TUMOR BURDEN, PROLIFERATION AND HOST IMMUNE STATUS, Blood, 90(10), 1997, pp. 1561-1561
Authors:
KAY NE
BONE N
LEONG T
OKEN MM
KYLE RA
VANNESS B
GREIPP PR
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPIC ANALYSIS OF BLOOD IMMUNE CELLS IN MYELOMA PATIENTS TREATED ON ECOG PROTOCOL E9486 - RELATIONSHIP OF IMMUNE CELLS TO TREATMENT AND CLINICAL OUTCOME, Blood, 90(10), 1997, pp. 1595-1595
Authors:
OKEN MM
KYLE RA
GREIPP PR
KAY NE
TSIATIS A
GREGORY SA
SPIEGEL RJ
OCONNELL MJ
Citation: Mm. Oken et al., COMPLETE REMISSION INDUCTION WITH COMBINED VBMCP CHEMOTHERAPY AND INTERFERON (RIFN(ALPHA-2B)) IN PATIENTS WITH MULTIPLE-MYELOMA, Leukemia & lymphoma, 20(5-6), 1996, pp. 447-452
Authors:
WESTENDORF JJ
AHMANN GJ
GREIPP PR
WITZIG TE
KYLE RA
LUST JA
JELINEK DF
Citation: Jj. Westendorf et al., ESTABLISHMENT AND CHARACTERIZATION OF 3 MYELOMA CELL-LINES THAT DEMONSTRATE VARIABLE CYTOKINE RESPONSES AND ABILITIES TO PRODUCE AUTOCRINE INTERLEUKIN-6, Leukemia, 10(5), 1996, pp. 866-876
Citation: J. Blade et al., PRESENTING FEATURES AND PROGNOSIS IN 72 PATIENTS WITH MULTIPLE-MYELOMA WHO WERE YOUNGER THAN 40 YEARS, British Journal of Haematology, 93(2), 1996, pp. 345-351
Authors:
WITZIG TE
GERTZ MA
LUST JA
KYLE RA
OFALLON WM
GREIPP PR
Citation: Te. Witzig et al., PERIPHERAL-BLOOD MONOCLONAL PLASMA-CELLS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH MULTIPLE-MYELOMA, Blood, 88(5), 1996, pp. 1780-1787